[Investigation of HL-antigens in cervical cancer patients (author's transl)].
Twenty-three of HL-antigens were investigated in 119 patients with clinical cancer and 230 female controls. Patients with cervical carcioma showed significant differences of some HLA frequencies from that of the controls. HLA-A 3 and A 28 were increased, HLA-A 1 was decreased. HL-antigens could be factors, together with others yet unknown, which produce an increased susceptibility to the disease.
D005260:Female; D006649:Histocompatibility Antigens / Q000032:analysis*; D006801:Humans; D002583:Uterine Cervical Neoplasms / Q000209:etiology / Q000276:immunology*
D006649:Histocompatibility Antigens
Untersuchungen zur Bedeutung der Histokompatibilitätsantigene bei Zervixkarzinompatientinnen